Activation and suppression of natural cellular immune functions by Pneumocystis carinii

Immunobiology

Volumn 198, Issue 4, 1998, Pages 343-360

  Warschkau, Holger ^a   Yu, Haixin ^a,b   Kiderlen, Albrecht F ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; LYMPHOTOXIN; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; LISTERIA MONOCYTOGENES; LUNG ALVEOLUS CELL; MALE; MICROORGANISM; MOUSE; NATURAL KILLER CELL; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; SCID MOUSE;

EID: 0031933857     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(98)80044-2     Document Type: Article

References (57)

1. CUSHION, M. T., S. L. STRINGER, and P. D. WALZER. 1991, Cellular and molecular biology of Pneumocystis carinii. Int. Rev. Cytol. 131: 59.
2. STRINGER, J. R., and P. D. WALZER. 1996. Molecular biology and epidemiology of Pneumocystis carinii infection in AIDS. AIDS 10: 561.
3. SU, T. H., and W. J. MARTIN II. 1994. Pathogenesis and host response in Pneumocystis carinii pneumonia. Annu. Rev. Med. 45: 261.
4. BANCROFT, G. J., M. J. BOSMA, G. C. BOSMA, and E. R. UNANUE. 1986. Regulation of macrophage Ia expression in mice with severe combined immunodeficiency: induction of Ia expression by a T cell-independent mechanism. J. Immunol. 137: 4.
5. BANCROFT, G. J., R. D. SCHREIBER, G. C. BOSMA, M. J. BOSMA, and E. R. UNANUE. 1987. A T cell-independent mechanism of macrophage activation by interferon-γ. J. Immunol. 139: 1104.
6. WHERRY, J. C., R. D. SCHREIBER, and E. R. UNANUE. 1991. Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect. Immun. 59: 1709.
7. BANCROFT, G. J., K. C. F. SHEEHAN, R. D. SCHREIBER, and E. R. UNANUE. 1989. Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. J. Immunol. 143: 127.
8. MCDONALD, V., and G. J. BANCROFT. 1994. Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice. Paras. Immunol. 16: 315.
9. SHER, A., I. P. OSWALD, S. HIENY, and R. T. GAZZINELLI. 1993. Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α. J. Immunol. 150: 3982.
10. TRIPP, C. S., S. F. WOLF, and E. R. UNANUE. 1993. Interleukin 12 and tumor necrosis factor α are costimulators of interferon-α production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiological antagonist. Proc. Natl. Acad. Sci. USA 90: 3725.
11. KAYE, P. M., and G. J. BANCROFT. 1992. Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro. Infect. Immun. 60: 4335.
12. BOSMA, G. C., R. P. CUSTER, and M. J. BOSMA. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301: 527.
13. DORSHKIND, K., S. B. POLLACK, M. J. BOSMA, and R. A. PHILLIPS. 1985. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J. Immunol. 134: 3798.
14. BANCROFT, G. J. 1993. The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 5: 503.
15. CUSHION, M. T., M. KASELIS, S. L. STRINGER, and J. R. STRINGER. 1993. Genetic stability and diversity of Pneumocystis carinii infecting rat colonies. Infect. Immun. 61: 4801.
16. DEI-CAS, E., J. C. CAILLIEZ, D. CAMUS, et al. 1996. In vitro systems in Pneumocystis research. Parasitol. Today 12: 245.
17. KIDERLEN, A. F., S. H. E. KAUFMANN, and M.-L. LOHMANN-MATTHES. 1984. Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon. Eur. J. Immunol. 14: 964.
18. 15N]-nitrate in biological fluids. Anal. Biochem. 126: 131.
19. r congenic mice. Infect. Immun. 59: 3935.
20. MOLL, H., K. BINÖDER, C. BOGDAN, W. SOLBACH, and M. RÖLLINCHOFF. 1990. Production of tumour necrosis factor during murine cutaneous leishmaniasis. Paras. Immunol. 12: 483.
21. ESKANDARI, M. K., D. T. NGUYEN, S. L. KUNKEL, and R. G. REMICK. 1990. WEHI 164 sub-clone 13 assay for TNF: sensitivity, specificity, and reliability. Analyt. Biochem. Immunol. Invest. 19: 69.
22. OKUNO, T., Y. TAKAGAKI, D. H. PLUZNIK, and J. Y. DJEU. 1986. Natural cytotoxic (NC) cell activity in basophilic cells: release of NC-specific cytotoxic factor by IgG receptor triggering. J. Immunol. 136: 4652.
23. MARCUCCI, F., B. KLEIN, H. KIRCHNER, and R. ZAWATZKY. 1982. Production of high titers of interferon-gamma by prestimulated murine spleen cells. Eur. J. Immunol. 12: 787.
24. ISHIDA, H., R. HASTINGS, J. KEARNEY, and M. HOWARD. 1992. Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J. Exp. Med. 175: 1213.
25. JULIUS, M. H., E. SIMPSON, and L. A. HERZENBERG. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3: 645.
26. AUSTYN, J. M., and S. GORDON. 1981. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11: 805.
27. KASAI, M., M. IWAMORI, Y. NAGAI, K. OKUMURA, and T. TADA. 1980. A glycolipid on the surface of mouse natural killer cells. Eur. J. Immunol. 10: 175.
28. KIESSLING, R., E. KLEIN, and H. WIGZELL. 1975. "Natural" killer cells in the mouse I. Cytotoxic cells with specificity for mouse moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5: 112.
29. HABU, S., H. FUKUI, K. SHIMAMURA, M. KASAI, Y. NAGAI, K. OKUMURA, and N. TAMAOKI. 1981. In vivo effects of anti-asialo GM1 I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J. Immunol. 127: 34.
30. + cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp. Med. 172: 937.
31. BONAGURA, V. R., S. L. CUNNINGHAM-RUNDLES, and S. SCHUVAL. 1992. Dysfunction of natural killer cells in human immunodeficiency virus-infected children with or without Pneumocystis carinii pneumonia. J. Pediatrics 121: 195.
32. MURRAY, H. W., B. Y. RUBIN, and C. D. ROTHERMEL. 1983. Killing of intracellular Leishmania donovani by lymphokine-stimulated mononuclear phagocytes. Evidence that IFN-γ is the activating lymphokine. J. Clin. Invest. 72: 1506.
33. BECK, J. M., H. D. LIGGITT, E. N. BRUNETTE, H. J. FUCHS, J. E. SHELLITO, and R. J. DEBS. 1991. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect. Immun. 59: 3859.
34. ISHIMINE, T., K. KAWAKAMI, A. NAKAMOTO, and A. SAITO. 1995. Analysis of cellular response and gamma-interferon synthesis in bronchoalveolar lavage fluid and lung homogenate of mice infected with Pneumocystis carinii. Microbiol. Immunol. 39: 49.
35. CHEN, W., E. A. HAVELL, and A. G. HARMSEN. 1992. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect. Immun. 60: 1279.
36. GARVY, B. A., R. A. B. EZEKOWITZ, and A. G. HARMSEN. 1997. Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection. Infect. Immun. 65: 373.
37. EHL, S., R. NUESCH, T. TANAKA, M. MYASAKA, H. HENGARTNER, and R. ZINKERNAGEL. 1996. A comparison of efficacy and specificity of three NK depleting antibodies. J. Immunol. Methods 199: 149.
38. HIBBS, J. B. Jr., Z. VAVRIN, and R. R. TAINTOR. 1987. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition of target cells. J. Immunol. 138: 550.
39. DOWNING, J. F., and W. J. MARTIN II. 1993. Interferon-gamma activated alveolar macrophages kill Pneumocystis carinii via induction of reactive nitrogen intermediates. Am. Rev. Respir. Dis. 147: A34.
40. SHELLITO, J. E., J. K. KOLLS, R. OLARIU, and J. M. BECK. 1996. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model. J. Infect. Dis. 173: 432.
41. PESANTI, E. L. 1991. Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro. J. Infect. Dis. 163: 611.
42. 125I-labelled tumor necrosis factor to Pneumocystis carinii and an insoluble cell wall fraction. J. Protozool. 38: 28S.
43. CORSINI, E., C. DYKSTRA, W. A. CRAIG, R. R. TIDWELL, and G. J. ROSENTHAL. 1992. Pneumocystis carinii induction of tumor necrosis factor-α by alveolar macrophages: modulation by pentamidine isethionate. Immunol. Letters 34: 303.
44. HOFFMAN, O. A., J. E. STANDING, and A. H. LIMPER. 1993. Pneumocystis carinii stimulates tumor necrosis factor-α release from alveolar macrophages through a beta-glucan-mediated mechanism. J. Immunol. 150: 3932.
45. TAMBURRINI, F., A. DE LUCA, G. VENTURA, G. MAIURO, A. SIRACUSANO, E. ORTONA, and A. ANTINORI. 1991. Pneumocystis carinii stimulates in vitro production of tumor necrosis factor-α by human macrophages. Med. Microbiol. Immunol. 180: 15.
46. HELMKE, R. J., and H. A. HIDALGO. 1992. Failure of Pneumocystis carinii to induce tumor necrosis factor and interleukin-6 in alveolar macrophages. Faseb J. 6: A1614.
47. MOORE, K. W., A. O'GARRA, R. DE WAAL MALEFYT, P. VIEIRA, and T. R. MOSMAN. 1993. Interleukin-10. Annu. Rev. Immunol. 11: 165.
48. D'ANDREA, A., M. ASTE-AMEZAGA, N. M. VALIANTE, X. MA, M. KUBIN, and G. TRINCHIERI. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ-production by suppression of natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178: 1041.
49. DE WAAL MALEFYT, R., J. ABRAMS, B. BENNETT, C. G. FIGDOR, and J. E. DE VRIES. 1991. IL-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209.
50. FIORENTINO, D. T., A. ZLOTNIK, T. R. MOSMAN, M. HOWARD, and A. O'GARRA. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815.
51. OSWALD, I. P., T. A. WYNN, A. SHER, and D. L. JANE. 1992. IL-10 inhibits macrophage microbicidal activity by inhibiting endogenous production of TNF-α required as costimulatory factor of IFN-γ-induced activation. Proc. Natl. Acad. Sci. 89: 8676.
52. ITO, M., M. WATANABE, H. KAMIYA, and M. SAKURAI. 1996. Inhibition of natural killer cell activity against cytomegalovirus-infected fibroblasts by nitric oxide-releasing agents. Cell. Immunol. 174: 13.
53. WAGNER, R. D., N. M. MAROUSHEK, J. F. BROWN, and C. J. CZUPRYNSKI. 1994. Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice. Infect. Immun. 62: 2345.
54. VAN DER POLL, T., A. MARCHANT, C. V. KEOGH, M. GOLDMAN, and S. F. LOWRY. 1996. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J. Infect. Dis. 174: 994.
55. CHEHIMI, J., X. MA, S. CHOUAIB, A. ZYAD, T. NAGASHUNMUGAM, L. WOJCIK, S. CHEHIMI, L. NISSIM, and I. FRANK. 1996. Differential production of interleukin 10 during human immunodeficiency virus infection. AIDS Res. Hum. Retroviruses 12: 1141.
56. GAZZINELLI, R. T., S. HIENY, S. WYNN, S. WOLF, and A. SHER. 1993. IL-12 is required for T lymphocyte independent induction of IFN-γ by an intracellular parasite and induces resistance in T cell deficient hosts. Proc. Natl. Acad. Sci. USA 90: 6115.
57. LASKAY, T., M. RÖLLINGHOFF, and W. SOLBACH. 1993. Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur. J. Immunol. 23: 2237.